Skip to main content

Fibroblastic/Myofibroblastic Tumors

  • Chapter
  • First Online:
Soft Tissue Pathology for Clinicians

Part of the book series: Pathology for Clinicians ((PACLIN))

  • 931 Accesses

Abstract

Fibroblastic and myofibroblastic tumors represent a large group of soft tissue neoplasms that are made up of cells resembling those found in tendons or ligaments. Fibroblasts appear as spindle cells with elongated nuclei and variable amounts of associated eosinophilic collagen deposition (Fig. 5.1). Myofibroblasts can be spindled or star-shaped and demonstrate some muscle-type antigens (e.g. smooth muscle actin) by immunohistochemistry. The behavior of these tumors can span from completely benign to malignant [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Goldblum J, Weiss S, Folpe AL, editors. Enzinger and weiss’s soft tissue tumors. 6th ed. Philadelphia: Elsevier; 2013.

    Google Scholar 

  2. Allen PW. Nodular fasciitis. Pathology. 1972;4(1):9–26.

    Article  CAS  PubMed  Google Scholar 

  3. Bernstein KE, Lattes R. Nodular (pseudosarcomatous) fasciitis, a nonrecurrent lesion: clinicopathologic study of 134 cases. Cancer. 1982;49(8):1668–78.

    Article  CAS  PubMed  Google Scholar 

  4. Shimizu S, Hashimoto H, Enjoji M. Nodular fasciitis: an analysis of 250 patients. Pathology. 1984;16(2):161–6.

    Article  CAS  PubMed  Google Scholar 

  5. Chung EB, Enzinger FM. Proliferative fasciitis. Cancer. 1975;36(4):1450–8.

    Article  CAS  PubMed  Google Scholar 

  6. Montgomery EA, Meis JM, Mitchell MS, Enzinger FM. Atypical decubital fibroplasia. A distinctive fibroblastic pseudotumor occurring in debilitated patients. Am J Surg Pathol. 1992;16(7):708–15.

    Article  CAS  PubMed  Google Scholar 

  7. Liegl B, Fletcher CD. Ischemic fasciitis: analysis of 44 cases indicating an inconsistent association with immobility or debilitation. Am J Surg Pathol. 2008;32(10):1546–52.

    Article  PubMed  Google Scholar 

  8. Chung EB, Enzinger FM. Fibroma of tendon sheath. Cancer. 1979;44(5):1945–54.

    Article  CAS  PubMed  Google Scholar 

  9. Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. Pathology and genetics of tumours of soft tissue and bone. 4th ed. Lyon: World Health Organization; 2013.

    Google Scholar 

  10. Goldblum JR, Folpe AL, Weiss SW, editors. Enzinger and weiss’s soft tissue tumors. 6th ed. Philadelphia: Saunders; 2013.

    Google Scholar 

  11. Pulitzer DR, Martin PC, Reed RJ. Fibroma of tendon sheath. A clinicopathologic study of 32 cases. Am J Surg Pathol. 1989;13(6):472–9.

    Article  CAS  PubMed  Google Scholar 

  12. Hornick JL, editor. Practical soft tissue pathology: a diagnostic approach. Philadelphia: Saunders; 2013.

    Google Scholar 

  13. Michal M, Fetsch JF, Hes O, Miettinen M. Nuchal-type fibroma: a clinicopathologic study of 52 cases. Cancer. 1999;85(1):156–63.

    Article  CAS  PubMed  Google Scholar 

  14. Balachandran K, Allen PW, MacCormac LB. Nuchal fibroma. A clinicopathological study of nine cases. Am J Surg Pathol. 1995;19(3):313–7.

    Article  CAS  PubMed  Google Scholar 

  15. Coffin CM, Hornick JL, Zhou H, Fletcher CD. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol. 2007;31(3):410–6.

    Article  PubMed  Google Scholar 

  16. Wehrli BM, Weiss SW, Yandow S, Coffin CM. Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Am J Surg Pathol. 2001;25(5):645–51.

    Article  CAS  PubMed  Google Scholar 

  17. Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology. 2007;51(4):509–14.

    Article  CAS  PubMed  Google Scholar 

  18. Hayes AJ, Alexander N, Clark MA, Thomas JM. Elastofibroma: a rare soft tissue tumour with a pathognomonic anatomical location and clinical symptom. Eur J Surg Oncol. 2004;30(4):450–3.

    Article  CAS  PubMed  Google Scholar 

  19. Allen PW. The fibromatoses: a clinicopathologic classification based on 140 cases. Am J Surg Pathol. 1977;1(3):255–70.

    Article  CAS  PubMed  Google Scholar 

  20. Noble J, Arafa M, Royle SG, McGeorge G, Crank S. The association between alcohol, hepatic pathology and Dupuytren’s disease. J Hand Surg (Br). 1992;17(1):71–4.

    Article  CAS  Google Scholar 

  21. Arkkila PE, Kantola IM, Viikari JS. Dupuytren’s disease: association with chronic diabetic complications. J Rheumatol. 1997;24(1):153–9.

    CAS  PubMed  Google Scholar 

  22. Stojadinovic A, Hoos A, Karpoff HM, Leung DH, Antonescu CR, Brennan MF, et al. Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment. Arch Surg. 2001;136(1):70–9.

    Article  CAS  PubMed  Google Scholar 

  23. Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol. 2010;102(5):380–4.

    Article  PubMed  Google Scholar 

  24. Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol. 1990;14(4):335–41.

    Article  CAS  PubMed  Google Scholar 

  25. Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I, et al. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol. 2012;25(12):1551–8.

    Article  PubMed  Google Scholar 

  26. Kasper B, Strobel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist. 2011;16(5):682–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Miettinen M, editor. Modern soft tissue pathology: tumors and non-neoplastic conditions. 1st ed. New York: Cambridge University Press; 2010.

    Google Scholar 

  28. Fukasawa Y, Takada A, Tateno M, Sato H, Koizumi M, Tanaka A, et al. Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II. Pathol Int. 1998;48(1):47–52.

    Article  CAS  PubMed  Google Scholar 

  29. Chilosi M, Facchettti F, Dei Tos AP, Lestani M, Morassi ML, Martignoni G, et al. Bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol. 1997;181(4):362–7.

    Article  CAS  PubMed  Google Scholar 

  30. Yoshida A, Tsuta K, Ohno M, Yoshida M, Narita Y, Kawai A, et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol. 2014;38(4):552–9.

    Article  PubMed  Google Scholar 

  31. Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25(9):1298–306.

    Article  PubMed  Google Scholar 

  32. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509–20.

    Article  PubMed  Google Scholar 

  33. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008;61(4):428–37.

    Article  CAS  PubMed  Google Scholar 

  34. Marino-Enriquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, et al. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011;35(1):135–44.

    Article  PubMed  Google Scholar 

  35. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer. 1962;15:717–25.

    Article  CAS  PubMed  Google Scholar 

  36. Fletcher CD, Evans BJ, MacArtney JC, Smith N, Wilson Jones E, McKee PH. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology. 1985;9(9):921–38.

    Article  CAS  PubMed  Google Scholar 

  37. Goldblum JR, Reith JD, Weiss SW. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up. Am J Surg Pathol. 2000;24(8):1125–30.

    Article  CAS  PubMed  Google Scholar 

  38. Gloster Jr HM, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35(1):82–7.

    PubMed  Google Scholar 

  39. Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD. Fibrosarcomatous (“high-grade”) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22(5):576–87.

    Article  CAS  PubMed  Google Scholar 

  40. Chung EB, Enzinger FM. Infantile fibrosarcoma. Cancer. 1976;38(2):729–39.

    Article  CAS  PubMed  Google Scholar 

  41. Schofield DE, Fletcher JA, Grier HE, Yunis EJ. Fibrosarcoma in infants and children. Application of new techniques. Am J Surg Pathol. 1994;18(1):14–24.

    Article  CAS  PubMed  Google Scholar 

  42. Rubin BP, Chen CJ, Morgan TW, Xiao S, Grier HE, Kozakewich HP, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153(5):1451–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer. 2014;120(6):799–807.

    Article  CAS  PubMed  Google Scholar 

  44. Folpe AL, Lane KL, Paull G, Weiss SW. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000;24(10):1353–60.

    Article  CAS  PubMed  Google Scholar 

  45. Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987;88(5):615–9.

    Article  CAS  PubMed  Google Scholar 

  46. Doyle LA, Moller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011;35(5):733–41.

    Article  PubMed  Google Scholar 

  47. Matsuyama A, Hisaoka M, Shimajiri S, Hashimoto H. DNA-based polymerase chain reaction for detecting FUS-CREB3L2 in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Diagn Mol Pathol. 2008;17(4):237–40.

    Article  CAS  PubMed  Google Scholar 

  48. Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Investig. 2005;85(3):408–15.

    Article  CAS  PubMed  Google Scholar 

  49. Evans HL. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol. 2011;35(10):1450–62.

    Article  PubMed  Google Scholar 

  50. Weiss SW, Enzinger FM. Myxoid variant of malignant fibrous histiocytoma. Cancer. 1977;39(4):1672–85.

    Article  CAS  PubMed  Google Scholar 

  51. Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, et al. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol. 1996;20(4):391–405.

    Article  CAS  PubMed  Google Scholar 

  52. Nascimento AF, Bertoni F, Fletcher CD. Epithelioid variant of myxofibrosarcoma: expanding the clinicomorphologic spectrum of myxofibrosarcoma in a series of 17 cases. Am J Surg Pathol. 2007;31(1):99–105.

    Article  PubMed  Google Scholar 

  53. Merck C, Angervall L, Kindblom LG, Oden A. Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl. 1983;282:1–40.

    CAS  PubMed  Google Scholar 

  54. Huang HY, Lal P, Qin J, Brennan MF, Antonescu CR. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol. 2004;35(5):612–21.

    Article  PubMed  Google Scholar 

  55. Bahrami A, Folpe AL. Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol. 2010;34(10):1504–13.

    Article  PubMed  Google Scholar 

  56. Hansen T, Katenkamp K, Brodhun M, Katenkamp D. Low-grade fibrosarcoma – report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types. Histopathology. 2006;49(2):152–60.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Perry, K. (2017). Fibroblastic/Myofibroblastic Tumors. In: Soft Tissue Pathology for Clinicians. Pathology for Clinicians. Springer, Cham. https://doi.org/10.1007/978-3-319-55654-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55654-3_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55653-6

  • Online ISBN: 978-3-319-55654-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics